Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

BACKGROUND: Application of repetitive transcranial magnetic stimulation (rTMS) for treating obsessive-compulsive disorder (OCD) has been promising and approved by the Food and Drug Administration in 2018, but effects differ between patients. Knowledge about clinical predictors of rTMS response may h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rostami, Reza, Kazemi, Reza, Jabbari, Arezoo, Madani, Azam Sadat, Rostami, Hosseinreza, Taherpour, Mohammad Amin, Molavi, Parviz, Jaafari, Nematollah, Kuo, Min-Fang, Vicario, Carmelo M., Nitsche, Michael A., Salehinejad, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364645/
https://www.ncbi.nlm.nih.gov/pubmed/32677923
http://dx.doi.org/10.1186/s12888-020-02769-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364645/
https://www.ncbi.nlm.nih.gov/pubmed/32677923
http://dx.doi.org/10.1186/s12888-020-02769-9

Ejemplares similares